Display Settings:

Format

Send to:

Choose Destination
    Vitam Horm. 2009;81:469-85.

    Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.

    Source

    Department of Medicine, Texas A&M Health Science Center, College of Medicine, Temple, Texas, USA.

    Abstract

    The endocannabinoid system comprises specific cannabinoid receptors such as Cb1 and Cb2, the endogenous ligands (anandamide and 2-arachidonyl glycerol among others) and the proteins responsible for their synthesis and degradation. This system has become the focus of research in recent years because of its potential therapeutic value several disease states. The following review describes our current knowledge of the changes that occur in the endocannabinoid system during carcinogenesis and then focuses on the effects of anandamide on various aspects of the carcinogenic process such as growth, migration, and angiogenesis in tumors from various origins.

    PMID:
    19647123
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2791688
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Figure 18.1
    Figure 18.3
    Figure 18.2

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk